Decellularized Adipose Tissue Scaffold for Soft Tissue Reconstruction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for soft tissue reconstruction, such as autologous fat transfer, face challenges including variable persistence, donor site morbidity, and post-operative calcifications, which can interfere with mammography readings and require multiple procedures, and are limited by the patient's adipose volume, especially in cancer patients undergoing chemotherapy or radiation.

Innovation Solution

Processed adipose tissue compositions are developed, including decellularized adipose tissue extracellular matrix that viable cells can attach to, which may include cross-linking agents, biopolymers, and other additives, and are prepared through methods like homogenization and nuclease treatment to reduce immunogenicity and lipid content, creating a biocompatible scaffold for tissue reconstruction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If autologous fat transfer is performed, then tissue restoration is achieved, but persistence varies widely (30-90%) and multiple procedures are required

Engineering Contradiction:
Improvepersistence of fat transferVSAvoidtime for multiple procedures
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent extracts and removes cellular components from adipose tissue through decellularization processes, isolating the extracellular matrix and specific cell populations (stromal vascular fraction) that provide structural support and regenerative capacity while removing elements that cause variability and degradation

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent applies chemical treatments (enzymes, detergents, cross-linking agents) and physical processes (supercritical fluid extraction, freeze-drying) to transform adipose tissue into a stable, standardized product with controlled properties that ensure consistent persistence and performance

Inventive Principle:
Principle #35Parameter changes

2Reliability

If muscle tissue is transferred for breast reconstruction, then reconstruction is achieved, but donor site morbidity and extended recovery time occur

Engineering Contradiction:
Improvereconstruction outcomeVSAvoiddonor site morbidity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts the beneficial components of adipose tissue (extracellular matrix, stromal vascular fraction cells) and separates them from the need for large-volume donor site harvesting, allowing reconstruction with minimal donor site impact

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates a composite material combining decellularized adipose extracellular matrix with viable stromal vascular fraction cells, producing a tissue-engineered construct that provides structural support and regenerative capacity without the morbidity of traditional muscle flap transfers

Inventive Principle:
Principle #40Composite materials

3Reliability

If adipose tissue is implanted, then tissue volume is restored, but post-operative calcifications occur that interfere with mammography

Engineering Contradiction:
Improvetissue restorationVSAvoidpost-operative calcifications
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent removes calcification-prone cellular components and lipid content through decellularization and extraction processes, leaving a purified extracellular matrix that does not undergo pathological calcification while maintaining tissue restoration capabilities

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent chemically modifies the adipose tissue through cross-linking and purification processes that alter its composition to prevent calcification while preserving the structural and aesthetic properties needed for tissue restoration

Inventive Principle:
Principle #35Parameter changes

4Adaptability or versatility

If patient's adipose volume is limited, then autologous fat transfer is constrained, but processed adipose tissue can be expanded

Engineering Contradiction:
Improveapplicability to cancer patientsVSAvoidadipose volume
Core Design Contradiction:
Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The patent performs preliminary harvesting and processing of adipose tissue from available donor sites, concentrating the beneficial components into a standardized product that can be stored and used when needed, allowing treatment of patients who would otherwise be ineligible due to insufficient adipose volume

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent creates a concentrated composite material from processed adipose tissue that provides enhanced volume and consistency, allowing reconstruction in patients with limited native adipose reserves by combining decellularized matrix with viable cell populations

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The processed adipose tissue compositions provide a predictable, long-lasting, and biocompatible material for soft tissue reconstruction, reducing the need for multiple procedures and minimizing donor site morbidity, while maintaining the native architecture and bioactivity of adipose tissue, suitable for clinical use in reconstructive and cosmetic surgeries.

Implementation Method 1

manipulating the adipose with one or more buffers sequentially to promote lipid and cell removal to prepare processed adipose tissue

Methodology Applied
Scientific EffectNuclease treatment: Enzyme

Implementation Method 2

the decellularized adipose includes cross-linking agent

Methodology Applied
Scientific EffectCross-linking: Chemical Bonding

Data Source

PatentUS20250011721A1Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
Publication Date: 2025.01.09 JOHNS HOPKINS UNIVERSITY
  • US20250011721A1 patent drawing
  • US20250011721A1 patent drawing
  • US20250011721A1 patent drawing

AI summary

The invention provides compositions and methods for the preparation of processed adipose tissue. The invention further provides methods of use of the processed adipose tissue.